NCT00000246已完成2 期
Rapid Benzodiazepine Detoxification Using Flumazenil
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 10
- 试验地点
- 2
- 主要终点
- Benzodiazepine withdrawal severity
研究概览
简要总结
The purpose of this study is to verify the hypothesis that the benzodiazepine antagonist, flumazenil, will reduce acute benzodiazepine withdrawal.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Benzodiazepine withdrawal severity
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
4 期
Impact of Flumazenil on the Emergence DeliriumAnesthesia, GeneralNCT05681377Korea University Guro Hospital68
撤回
1 期
Treatment of Hepatic Encephalopathy With Flumazenil and Change in Cortical GABA Levels in MRSLiver CirrhosisHepatic EncephalopathyNCT02048969Yale University
已完成
2 期
Bazedoxifene Acetate as a Remyelinating Agent in Multiple SclerosisMultiple SclerosisMultiple Sclerosis, Relapsing-RemittingNCT04002934Riley Bove, MD63
已完成
1 期
Benzodiazepine-free Anesthetic for Reduction of Delirium (B-Free)Post-operative DeliriumNCT03053869McMaster University480
已完成
不适用
Reversal of Remimazolam by a Single Dose of FlumazenilFlumazenil Adverse ReactionAmbulatory SurgeryPostoperative NauseaRemimazolamNCT05382806Konkuk University Medical Center224
